Holen Sie sich die Stockscreener-App
1.31
9.17%
0.11
Handel nachbörslich:
1.23
-0.08
-6.11%
Finanzdaten der Rapt Therapeutics Inc-Aktie (RAPT)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
2.10%
32.52
|
33.22 | 33.92 | 28.36 | 31.56 |
| Depreciation and Amortization |
2.79%
0.314
|
0.323 | 0.30 | 0.30 | 0.299 |
| Operating Income/Loss |
2.10%
-32.52
|
-33.22 | -33.92 | -28.36 | -31.56 |
| Nonoperating Income/Loss |
14.69%
1.997
|
2.341 | 2.548 | 3.084 | 2.291 |
| Income/Loss From Continuing Operations Before Tax |
1.15%
-30.52
|
-30.88 | -31.37 | -25.28 | -29.27 |
| Income/Loss From Continuing Operations After Tax |
1.15%
-30.52
|
-30.88 | -31.37 | -25.28 | -29.27 |
|
Net Income/Loss
|
1.15%
-30.52
|
-30.88 | -31.37 | -25.28 | -29.27 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
250.91K%
38.63
|
0.0154 | 38.36 | 38.33 | 38.28 |
| Diluted Average Shares |
250.91K%
38.63
|
0.0154 | 38.36 | 38.33 | 38.28 |
| Basic Earnings Per Share |
2.47%
-0.79
|
-0.81 | -0.82 | -0.66 | -0.76 |
| Diluted Earnings Per Share |
2.47%
-0.79
|
-0.81 | -0.82 | -0.66 | -0.76 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.19%
1.46%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):